227 related articles for article (PubMed ID: 28060329)
1. Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System.
Regan K; Moosavinasab S; Payne P; Lin S
J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060329
[TBL] [Abstract][Full Text] [Related]
2. 'RE:fine drugs': an interactive dashboard to access drug repurposing opportunities.
Moosavinasab S; Patterson J; Strouse R; Rastegar-Mojarad M; Regan K; Payne PR; Huang Y; Lin SM
Database (Oxford); 2016; 2016():. PubMed ID: 27189611
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
Turanli B; Gulfidan G; Arga KY
OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
[TBL] [Abstract][Full Text] [Related]
4. Computational Drug Repurposing: Current Trends.
Karaman B; Sippl W
Curr Med Chem; 2019; 26(28):5389-5409. PubMed ID: 29848268
[TBL] [Abstract][Full Text] [Related]
5. Web-based drug repurposing tools: a survey.
Sam E; Athri P
Brief Bioinform; 2019 Jan; 20(1):299-316. PubMed ID: 29028878
[TBL] [Abstract][Full Text] [Related]
6. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
Wang Y; Yella J; Jegga AG
Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
[TBL] [Abstract][Full Text] [Related]
8. Implementation of a Pipeline Using Disease-Disease Associations for Computational Drug Repurposing.
Balasundaram P; Kanagavelu R; James N; Maiti S; Veerappapillai S; Karuppaswamy R
Methods Mol Biol; 2019; 1903():129-148. PubMed ID: 30547440
[TBL] [Abstract][Full Text] [Related]
9. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
Karatzas E; Kolios G; Spyrou GM
Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
[TBL] [Abstract][Full Text] [Related]
10. An update on Drug Repurposing: Re-written saga of the drug's fate.
Gns HS; Gr S; Murahari M; Krishnamurthy M
Biomed Pharmacother; 2019 Feb; 110():700-716. PubMed ID: 30553197
[TBL] [Abstract][Full Text] [Related]
11. In silico drug repositioning: what we need to know.
Liu Z; Fang H; Reagan K; Xu X; Mendrick DL; Slikker W; Tong W
Drug Discov Today; 2013 Feb; 18(3-4):110-5. PubMed ID: 22935104
[TBL] [Abstract][Full Text] [Related]
12. The prescribable drugs with efficacy in experimental epilepsies (PDE3) database for drug repurposing research in epilepsy.
Sivapalarajah S; Krishnakumar M; Bickerstaffe H; Chan Y; Clarkson J; Hampden-Martin A; Mirza A; Tanti M; Marson A; Pirmohamed M; Mirza N
Epilepsia; 2018 Feb; 59(2):492-501. PubMed ID: 29341109
[TBL] [Abstract][Full Text] [Related]
13. A new computational drug repurposing method using established disease-drug pair knowledge.
Saberian N; Peyvandipour A; Donato M; Ansari S; Draghici S
Bioinformatics; 2019 Oct; 35(19):3672-3678. PubMed ID: 30840053
[TBL] [Abstract][Full Text] [Related]
14. Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data.
Khosravi A; Jayaram B; Goliaei B; Masoudi-Nejad A
Mol Med; 2019 Jun; 25(1):30. PubMed ID: 31221082
[TBL] [Abstract][Full Text] [Related]
15. Literature mining, ontologies and information visualization for drug repurposing.
Andronis C; Sharma A; Virvilis V; Deftereos S; Persidis A
Brief Bioinform; 2011 Jul; 12(4):357-68. PubMed ID: 21712342
[TBL] [Abstract][Full Text] [Related]
16. Computational functional genomics-based approaches in analgesic drug discovery and repurposing.
Lippmann C; Kringel D; Ultsch A; Lötsch J
Pharmacogenomics; 2018 Jun; 19(9):783-797. PubMed ID: 29792109
[TBL] [Abstract][Full Text] [Related]
17. Drug repurposing: a promising tool to accelerate the drug discovery process.
Parvathaneni V; Kulkarni NS; Muth A; Gupta V
Drug Discov Today; 2019 Oct; 24(10):2076-2085. PubMed ID: 31238113
[TBL] [Abstract][Full Text] [Related]
18. PS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signatures.
Emon MA; Domingo-Fernández D; Hoyt CT; Hofmann-Apitius M
BMC Bioinformatics; 2020 Jun; 21(1):231. PubMed ID: 32503412
[TBL] [Abstract][Full Text] [Related]
19. Drug repurposing and adverse event prediction using high-throughput literature analysis.
Deftereos SN; Andronis C; Friedla EJ; Persidis A; Persidis A
Wiley Interdiscip Rev Syst Biol Med; 2011; 3(3):323-34. PubMed ID: 21416632
[TBL] [Abstract][Full Text] [Related]
20. Literature-based discovery of new candidates for drug repurposing.
Yang HT; Ju JH; Wong YT; Shmulevich I; Chiang JH
Brief Bioinform; 2017 May; 18(3):488-497. PubMed ID: 27113728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
